ControlPoint CEO to Present at BIOFUTURE™

Animal diagnostics startup among future-focused thinkers shaping the future of therapeutics

Campbell, Calif. - ControlPoint CEO Dr. Paula Walker announced that she will present at BioFuture, a gathering of top innovators, investors and business leaders discussing the forces shaping the future of therapeutics.  BioFuture is also focused on identifying the potential of innovative, game-changing technologies that will drive the future of drug discovery. 

Dr. Walker will introduce ControlPoint to in-person investors and business leaders Wednesday, Nov. 17 at 11:50 EST; her recorded presentation is also available at biofuture.com.

“Presenting at BioFuture is an honor for us and will enable us to continue our work in bringing a fast, cost-effective and easy-to-use solution for canine infectious respiratory disease (CIRD) to veterinarians,” said Dr. Walker.  “Kennel cough is a common but debilitating ailment.  Increased awareness will allow us to move ahead to bring point-of-service testing to animal health providers.” 

“We are delighted that ControlPoint will be presenting at this important event. Their diagnostic testing is truly an innovative solution for many in veterinary medicine,” said Sara Demy, CEO of Demy-Colton. 

ABOUT BIOFUTURE

BioFuture is a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Therapeutics”. BioFuture will be held in-person in New York City on November 7-9, 2022, at the Lotte Palace Hotel, with a virtual access option for digital partnering and recorded content on November 14-16.  BioFuture features multiple tracks of plenary sessions, presenting companies, workshops, networking, and an opportunity to schedule one-to-one meetings. BioFuture is produced by Demy-Colton, a leading life sciences and digital health events organization, with a long history of producing high-quality events that build networks between innovative life sciences companies and industry stakeholders.

ABOUT CONTROLPOINT INC..

ControlPoint Inc. is an animal diagnostics company focused on developing tests that could be used by anyone, anywhere, providing results within minutes. We are currently working on a point-of-care test that identifies multiple pathogens, providing veterinarians with an easy-to-use and fast test.  To learn more, visit www.controlpointdx.com.

For press inquiries contact info@controlpointdx.com or Sharon Polk, 913-221-5834; spolk@dmgcommunication.com